Skip to content

The comparison of analgesic effect of haloperidol plus morphin with morphin alone in patients with acute renal colic presenting to emergency department

The comparison of analgesic effect of haloperidol plus morphin with morphin alone in patients with acute renal colic presenting to emergency department

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015092224136N1
Enrollment
140
Registered
2015-11-22
Start date
2015-08-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urilothiasis. Calculus of kidney and ureter

Interventions

Intervention 1: Intervention Group: Morphine Sulfate intravenously 0.1 mg per kilogram (Dr. Abidi manufacturer) Haloperidol 5mg intramuscular (Iran Pharma manufacturer) Fentanyl 1mcg per kilogram intr
Treatment - Drugs
Intervention Group: Morphine Sulfate intravenously 0.1 mg per kilogram (Dr. Abidi manufacturer) Haloperidol 5mg intramuscular (Iran Pharma manufacturer) Fentanyl 1mcg per kilogram intravenously (Iran
Control group: Morphine sulfate 0.1mg per kilogram intravenously (Dr. Abidi manufacturer) Fentanyl 1mcg per kilogram intravenously (Iran Pharma manufacturer)

Sponsors

Vice challencor for reasearch of Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: clinical and para-clinical evidence of renal colic in 18-55 years old patients with flank pain exclusion criteria: decreased level of consciousness; age below 18 or above 55 years old; renal disease; heart disease; pregnancy; allergy to haloperidol or morphine; severe side effects like nausea and vomiting

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
Nausea and Vomiting. Timepoint: ?Before Intervention, 20 Minutes after intervention, 40 minutes after intervention, 60 minutes after intervention. Method of measurement: Questionnaire.;Extrapyramidal side effects. Timepoint: ?Before Intervention, 20 Minutes after intervention, 40 minutes after intervention, 60 minutes after intervention. Method of measurement: Questionnaire.

Primary

MeasureTime frame
Visual analoge scale for pain. Timepoint: Before intervention, 20 minutes after intervention, 40 minutes after intervention, 60 minutes after intervention. Method of measurement: millimeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Delirrooyfard

Ahvaz Jundishapur University of Medical Sciences

Adelir1982@gmil.com+98 61 3222 2922

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026